Overview
Key Metrics Quarterly
P&L
Balance Sheet
Cash Flows
Ratios
Shareholding
Documents
About
Biocon Limited, together with its subsidiaries, manufactures biotechnology products and offers research services in India, the United States, Ireland, rest of the European Union, and internationally. It operates through Generics; Biosimilars; and Contract Research, Development and Manufacturing Organization (CRDMO) segments. The company offers generic formulations and API products, including cardiovascular, anti-diabetics, obesity, central nervous system, anti-cancer/oncology, multiple sclerosis, immunosuppressants, and specialty molecules; and biosimilars products for oncology, diabetes, and immunology therapeutic areas. It also provides integrated discovery, development, and manufacturing services to pharmaceutical, biotechnology, animal health, consumer goods, and specialty chemical industries, as well as academic institutions, non-profit organizations, and government agencies. In addition, the company offers enzyme, biopharmaceutical, and medicinal goods; contract research and manufacturing services; clinical research; and business support and development, and marketing services. Biocon Limited was incorporated in 1978 and is headquartered in Bengaluru, India.
Key Metrics
as of Sep 2026
Market Cap 64,764 Cr
P/E 89.00
Div Yield 0.13 %
Book Value βΉ210.00
52w High βΉ447.00
52w Low βΉ337.00
Face Value βΉ5.00
Quarterly Results
Rs. Crores Β· hover row for definition
Metric
Jun 2026
Mar 2026
Dec 2025
Sep 2025
Jun 2025
Mar 2025
Dec 2024
Sep 2024
Jun 2024
Mar 2024
Dec 2023
Sep 2023
Jun 2023
Sales
624.00
605.00
621.00
583.00
537.00
644.00
563.00
525.00
511.00
533.00
563.00
519.00
513.00
Expenses
564.00
525.00
548.00
530.00
516.00
582.00
532.00
488.00
466.00
480.00
492.00
452.00
441.00
Operating Profit
61.00
79.00
73.00
53.00
21.00
62.00
31.00
38.00
45.00
52.00
71.00
67.00
72.00
OPM %
10.00
13.00
12.00
9.00
3.80
10.00
6.00
7.00
9.00
10.00
13.00
13.00
14.00
Other Income
65.00
31.00
-122.00
134.00
61.00
63.00
672.00
74.00
42.00
39.00
48.00
64.00
56.00
Depreciation
38.00
36.00
34.00
34.00
33.00
33.00
34.00
30.00
30.00
30.00
31.00
31.00
30.00
Interest
17.00
17.00
2.00
67.00
56.00
57.00
65.00
60.00
55.00
40.00
56.00
55.00
48.00
Profit before tax
70.00
57.00
-84.00
86.00
-8.00
35.00
604.00
21.00
1.00
22.00
33.00
46.00
50.00
Tax %
25.00
11.00
-10.00
17.00
9.00
39.00
3.00
85.00
18.00
36.00
27.00
25.00
6.00
Net Profit
52.00
51.00
-76.00
71.00
-8.00
21.00
584.00
3.00
1.00
14.00
24.00
35.00
47.00
EPS in Rs
0.32
0.31
-0.57
0.53
-0.06
0.18
4.86
0.03
0.01
0.12
0.20
0.29
0.39
Profit & Loss
Annual Β· Rs. Crores
Metric
Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar 2018 Mar 2017 Mar 2016 Mar 2015
Sales
2,346.00 2,243.00 2,127.00 1,993.00 1,738.00 2,028.00 1,988.00 1,786.00 2,419.00 2,588.00 2,302.00 2,242.00
Expenses
2,120.00 2,066.00 1,864.00 1,969.00 1,677.00 1,716.00 1,702.00 1,575.00 2,101.00 1,996.00 1,880.00 1,812.00
Operating Profit
226.00 177.00 264.00 24.00 61.00 312.00 286.00 210.00 318.00 592.00 422.00 430.00
OPM %
10.00 8.00 12.00 1.20 3.50 15.00 14.00 12.00 13.00 23.00 18.00 19.00
Other Income
105.00 848.00 206.00 3,134.00 187.00 150.00 366.00 422.00 125.00 99.00 279.00 127.00
Interest
142.00 237.00 199.00 70.00 0.00 0.00 1.00 3.00 1.00 4.00 2.00 1.00
Depreciation
137.00 128.00 121.00 117.00 108.00 104.00 98.00 92.00 136.00 151.00 140.00 128.00
Profit before tax
51.00 661.00 150.00 2,971.00 140.00 359.00 553.00 537.00 306.00 536.00 559.00 428.00
Tax %
27.00 8.00 21.00 4.00 38.00 22.00 20.00 8.00 22.00 3.00 34.00 16.00
Net Profit
37.00 609.00 119.00 2,848.00 86.00 280.00 441.00 493.00 238.00 519.00 369.00 361.00
EPS in Rs
0.23 5.07 0.99 23.72 0.72 2.34 3.67 4.11 1.99 4.33 3.07 3.01
Dividend Payout %
218.00 10.00 50.00 6.00 70.00 0.00 0.00 12.00 25.00 12.00 27.00 28.00
Balance Sheet
Annual Β· Rs. Crores β latest first
Metric
Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar 2018 Mar 2017 Mar 2016 Mar 2015
Equity Capital
810.00 600.00 600.00 600.00 600.00 600.00 600.00 300.00 300.00 100.00 100.00 100.00
Reserves
26,269.00 10,924.00 10,312.00 10,316.00 7,493.00 7,307.00 6,937.00 6,815.00 6,439.00 6,441.00 5,897.00 2,484.00
Borrowings
1,153.00 2,876.00 2,043.00 1,301.00 77.00 2.00 4.00 71.00 133.00 134.00 370.00 82.00
Other Liabilities
1,038.00 1,221.00 813.00 813.00 699.00 665.00 770.00 1,054.00 855.00 794.00 732.00 667.00
Total Liabilities
29,271.00 15,621.00 13,768.00 13,030.00 8,869.00 8,574.00 8,311.00 8,240.00 7,727.00 7,469.00 7,098.00 3,333.00
Fixed Assets
1,381.00 1,114.00 958.00 961.00 870.00 798.00 793.00 1,101.00 903.00 938.00 894.00 914.00
CWIP
541.00 701.00 560.00 344.00 285.00 179.00 152.00 254.00 318.00 241.00 172.00 58.00
Investments
24,978.00 11,383.00 9,318.00 9,271.00 5,280.00 5,413.00 4,953.00 4,093.00 4,199.00 3,888.00 3,853.00 165.00
Other Assets
2,371.00 2,424.00 2,932.00 2,454.00 2,434.00 2,184.00 2,413.00 2,792.00 2,307.00 2,402.00 2,179.00 2,196.00
Total Assets
29,271.00 15,621.00 13,768.00 13,030.00 8,869.00 8,574.00 8,311.00 8,240.00 7,727.00 7,469.00 7,098.00 3,333.00
Cash Flows
Annual Β· Rs. Crores β latest first
Metric
Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar 2018 Mar 2017 Mar 2016 Mar 2015
Cash from Operating Activity
-180.00 624.00 -123.00 219.00 48.00 478.00 387.00 110.00 355.00 186.00 208.00 125.00
Cash from Investing Activity
-6,580.00 -992.00 -295.00 -1,173.00 -302.00 -628.00 -189.00 315.00 -553.00 104.00 -313.00 145.00
Cash from Financing Activity
6,602.00 495.00 344.00 1,039.00 112.00 28.00 -129.00 -208.00 -55.00 -238.00 73.00 -158.00
Net Cash Flow
-158.00 127.00 -74.00 86.00 -142.00 -122.00 69.00 217.00 -252.00 52.00 -32.00 112.00
Free Cash Flow
-469.00 302.00 -429.00 -45.00 -197.00 420.00 195.00 -148.00 186.00 -42.00 -11.00 67.00
CFO/OP %
-70.00 376.00 -36.00 1,103.00 124.00 173.00 167.00 117.00 139.00 52.00 98.00 48.00
Ratios
Annual Β· Days / % β latest first
Metric
Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar 2018 Mar 2017 Mar 2016 Mar 2015
Debtor Days
156.00 135.00 180.00 121.00 147.00 106.00 105.00 184.00 112.00 113.00 80.00 90.00
Inventory Days
299.00 296.00 260.00 208.00 245.00 197.00 236.00 371.00 195.00 190.00 187.00 148.00
Days Payable
201.00 288.00 175.00 169.00 172.00 170.00 230.00 298.00 202.00 159.00 146.00 109.00
Cash Conversion Cycle
254.00 143.00 265.00 159.00 220.00 133.00 111.00 257.00 105.00 144.00 121.00 129.00
Working Capital Days
9.00 30.00 244.00 151.00 181.00 122.00 154.00 214.00 87.00 108.00 42.00 76.00
ROCE %
2.00 2.00 3.00 2.00 2.00 5.00 5.00 5.00 4.00 8.00 10.00 17.00
Shareholding Pattern
% holding β latest first
Quarterly
Yearly
Holder
Jun 2026
Mar 2026
Dec 2025
Sep 2025
Jun 2025
Mar 2025
Dec 2024
Sep 2024
Jun 2024
Mar 2024
Dec 2023
Sep 2023
Promoters
44.68
44.91
54.45
54.45
54.45
60.64
60.64
60.64
60.64
60.64
60.64
60.64
FIIs
8.14
7.52
7.39
6.61
6.04
5.67
5.66
5.93
5.90
5.63
6.55
7.97
DIIs
23.33
24.01
21.67
22.06
22.83
15.73
15.36
14.44
14.29
13.69
14.51
14.08
Public
23.75
23.40
16.34
16.70
16.51
17.77
18.11
18.74
18.90
19.74
17.96
16.92
No. of Shareholders
392,833
386,593
394,279
413,191
428,131
424,297
427,705
439,503
443,513
470,261
434,339
415,046
Corporate Actions
28 records
Back to all stocks